cell
key
player
immun
respons
intracellular
infect
tumour
recognit
intracellular
viral
protein
cytotox
lymphocyt
requir
initi
cytosol
proteolyt
process
proteasom
peptid
product
transloc
transport
associ
antigen
process
tap
endoplasm
reticulum
er
assembl
major
histocompat
complex
mhc
class
molecul
present
cell
surfac
peptid
releas
proteasom
cytosol
promptli
degrad
cytosol
endopetidas
aminopeptidas
singl
amino
acid
escap
bind
tap
enter
er
calcul
one
peptid
bind
mhc
class
molecul
degrad
protein
explain
rel
subtl
effici
antigen
present
class
molecul
coupl
cervic
cancer
cell
well
number
malign
tumour
often
show
regul
subset
case
complet
loss
mhc
class
express
like
mechan
immun
escap
previou
studi
shown
antigen
link
calreticulin
crt
abund
kd
protein
locat
er
directli
express
er
avoid
cytoplasm
degrad
way
antigen
molecul
would
avail
degrad
er
larger
number
peptid
might
gener
load
onto
mhci
strategi
peptidespecif
tcell
respons
antigenantitumour
activ
murin
model
cervic
uterin
cancer
enhanc
fusion
human
papilloma
viru
antigen
crt
howev
mechan
involv
remain
poorli
understood
significantli
crt
shown
gener
greatest
immun
respons
compar
adjuv
fusion
sort
signal
lysosomeassoci
membran
protein
mycobacterium
tuberculosi
heatshock
protein
transloc
domain
pseudomona
aeruginosa
exotoxin
simplifi
strategi
determin
antitumour
properti
confer
calreticulin
depend
abil
retain
er
engin
new
version
gene
bear
signal
requir
er
target
signal
peptid
sp
mllpvplllgllglaaal
er
retent
kdel
previous
shown
vaccin
adenoviru
express
crt
chimer
link
antigen
caus
stronger
immun
respons
compar
vaccin
adenoviru
vector
express
protein
herein
construct
adenoviru
express
antigen
sp
amino
end
kdel
sequenc
carboxyl
end
fig
detail
adenovir
construct
see
support
inform
adenoviru
product
human
embryon
kidney
cell
infect
differ
adenovirus
lacz
protein
extract
analys
western
blot
shown
fig
adenoviru
express
kd
protein
expect
contrast
kd
band
express
adenoviru
demonstr
fusion
protein
distribut
er
immunofluoresc
stain
cell
infect
differ
adenovirus
use
antibodi
protein
calnexin
wellcharacter
marker
er
previou
studi
laboratori
other
demonstr
cytoplasmicnuclear
local
lost
fusion
calreticulin
sequest
er
shown
fig
red
signal
coloc
calnexin
protein
green
signal
confirm
distribut
er
similarli
bear
sp
er
retent
sequenc
crt
pattern
calnexin
marker
demonstr
signal
sequenc
ad
crt
abl
replac
function
er
retent
evalu
sp
kdel
signal
adjuv
effect
crt
group
femal
adult
mice
treat
adenoviru
express
either
analys
level
interferon
ifn
signatur
cytokin
respons
effector
function
cell
critic
tumour
erad
previous
shown
fusion
crt
increas
five
time
releas
splenocyt
mice
immun
adenoviru
express
fusion
pgml
versu
adenoviru
express
pgml
increas
eight
time
versu
adenoviru
express
lacz
pgml
shown
fig
confirm
splenocyt
mice
immun
gener
signific
level
stimul
vitro
epitop
respons
upon
immun
adenoviru
express
show
also
signific
induct
eight
time
control
adlacz
evalu
protect
effect
chimer
protein
murin
tumor
model
purpos
group
femal
adult
mice
challeng
murin
tumour
cell
design
week
immun
adenoviru
express
lacz
seen
fig
rapid
tumour
growth
observ
group
mice
immun
control
adenoviru
express
lacz
kill
expect
immun
adenoviru
express
protect
mice
tumour
develop
poor
immunogen
mice
kill
well
contrast
mice
vaccin
adenoviru
express
elimin
tumour
similar
protect
effect
demonstr
sp
kdel
signal
enough
enhanc
antitumour
immun
respons
taken
togeth
result
indic
adjuv
antitumour
effect
attribut
crt
mainli
confer
sp
kdel
sequenc
allow
antigen
enter
maintain
er
kdel
sequenc
emerg
signific
antitumour
immun
sequenc
recent
shown
dendrit
cell
load
exogen
peptid
bear
kdel
motif
show
effici
antitumour
activ
dendrit
cell
puls
peptid
without
kdel
even
though
mechan
epitop
gener
er
poorli
understood
kdel
sequenc
might
result
longer
traffick
time
er
increas
possibl
degrad
consequ
peptid
gener
load
molecul
worth
determin
contribut
sp
adjuv
effect
compar
addit
sp
kdel
sequenc
anoth
advantag
strategi
prevent
put
advers
effect
caus
overexpress
crt
exampl
role
storag
transport
er
demonstr
fusion
crt
also
enhanc
humor
respons
antigen
receptorbind
domain
domain
iv
protect
antigen
pa
div
bacillu
anthraci
sar
coronaviru
antigen
even
though
pathway
unknown
expect
strategi
might
potenti
respons
well
conclus
target
antigen
er
confer
strike
immunogen
potenti
gene
cancer
therapi
work
repres
import
contribut
basic
research
futur
clinic
translat
